Medical Doctor Program year 2025 Reported 2020–2025 Source: CMS Open Payments, 2026 publication

Robert Steiner

Clinical Genetics (M.D.) Madison, WI Medical Doctor

NPI 1982612420 CMS profile 1188325

1500 Highland Ave, Madison, WI 53705

Open in the dashboard

General payments

$77,372

75 records reported · program years 2020–2025

Research payments

$0

Paid to them · None reported · program years 2020–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$5,000 paid to institutions, not to them · program year 2020

Through program year 2025, Robert Steiner of Madison, WI is reported in the CMS Open Payments database as having received $77,372 across 75 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $5,000 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 92nd percentile of Clinical Genetics (M.D.) profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $23,191 25
2024 General $24,638 15
2023 General $18,764 26
2022 General $4,656 5
2021 General $5,550 2
2020 General $574 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Robert Steiner
  • Clinical Genetics (M.D.) median
  • Middle half of Clinical Genetics (M.D.)
  • National median

In program year 2025, general payments to Robert Steiner were reported at $23,191. Among 315 Clinical Genetics (M.D.) profiles paid that year, the median was $255 and the middle half received between $85 and $3,583.

Show as a table
Year Robert Steiner Clinical Genetics (M.D.) median Middle half National median
2019 $0 $130 $24–$2,691 $163
2020 $574 $126 $30–$3,700 $114
2021 $5,550 $185 $30–$3,777 $132
2022 $4,656 $136 $44–$2,749 $149
2023 $18,764 $196 $55–$5,220 $160
2024 $24,638 $165 $46–$3,171 $164
2025 $23,191 $255 $85–$3,583 $169

Breakdown

Who paid General payments · program years 2020–2025
  1. Mirum Pharmaceuticals, Inc. $40,643 32 payments
  2. Retrophin, Inc. $15,160 7 payments
  3. PTC Therapeutics, Inc. $10,702 23 payments
  4. Amgen Inc. $8,233 7 payments
  5. Leadiant Biosciences, Inc. $2,325 3 payments
  6. BioMarin Pharmaceutical Inc. $156 1 payment
  7. Genzyme Corporation $128 1 payment
  8. Orchard Therapeutics North America $25 1 payment

Every payment, record by record

What the payments were for General payments · program years 2020–2025
  1. Consulting Fee $67,386 30 payments
  2. Travel and Lodging $7,437 19 payments
  3. Food and Beverage $2,136 25 payments
  4. Education $414 1 payment
Products named General payments · program years 2020–2025
  1. Chenodal $28,826 12 payments
  2. CHOLBAM Rare Disease $14,788 16 payments
  3. Cholbam Hepatology $11,886 7 payments
  4. Livmarli $11,869 8 payments
  5. CTEXLI $10,551 8 payments
  6. PROCYSBI $8,171 6 payments
  7. Palynziq $156 1 payment
  8. EMFLAZA $63 1 payment
  9. RAVICTI $62 1 payment
  10. LENMELDY $25 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

75 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Genetics (M.D.) in Wisconsin

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record